The Morning Report: Biotech firm notches US$85 million in funding

Plus 10 other headlines from the last 24 hours.

The Morning Report, a daily digest of Vancouver tech news, is still in beta. If someone sent you this, and you’d like to be added to our ongoing pilot, join the waitlist here.

Good Morning,

Here’s what you need to know today.

Notch Therapeutics, a Vancouver biotechnology company developing a platform to produce immune cells on an industrial scale for treat…

This post is for paying subscribers